Preparation and application of Ce6@PDNs-SAP with wet adhesion, photodynamic antibacterial and in situ remineralization promotion functions
Ce6@PDNs-SAP was prepared by combining Ce6 with the dendritic polypeptide nanogel and the six peptide sequences of the N-terminal fertile casein, which solved the stability and antibacterial effect of photosensitizer in the oral environment and achieved caries Effective prevention and remineralization of enamel provide a safe and comprehensive strategy for caries prevention and control.
Patent Information
- Application Number
- CN202411322976.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2024-08-15
- Filing Date
- 2024-09-23
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-09-23
AI Technical Summary
The existing photosensitizers of antibacterial photodynamic therapy are insufficiently hydrophilic, which makes it difficult to stabilize adhesion and long-term retention in the oral saliva microenvironment, and cannot effectively prevent and treat caries. Traditional caries prevention drugs have drug resistance and side effects.
Ce6@PDNs-SAP was prepared by chemically modifying dendritic polypeptide nanogels (PDNs) and six peptide sequences of rich casein N-terminal (SAP), which enhanced its wet adhesion ability and mediated photodynamic antibacterial The role of the combination promotes the in-situ remineralization of the hard tissue of the tooth.
Ce6@PDNs-SAP can quickly adhere and stay on the tooth surface for a long time, significantly reducing the survival rate of caries-causing bacteria, and significantly promoting the remineralization of enamel under light, forming a dense and smooth new regenerated mineral layer, solving traditional photosensitive Problems with the stability and antibacterial effect of the agent in the oral environment.
Smart Images

Figure CN118846053B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomedical material preparation, and in particular to the preparation of Ce6@PDNs-SAP having the functions of wet adhesion, photodynamic antibacterial and in-situ promotion of remineralization, and its application in the preparation of dental caries prevention gargle. Background Art
[0002] Dental caries has become a major challenge affecting global health due to its high prevalence and high treatment failure rate. Dental caries is caused by cariogenic bacteria in the oral cavity metabolizing carbohydrates to produce acidic substances, which then destroy the hard tissues of the teeth and cause demineralization. The specific manifestation of bacterial-mediated demineralization of hard tissues of the teeth is that non-empty chalky lesions can be observed on the tooth surface in the early stage of dental caries. At this stage, substantial caries lesions have not yet formed and treatment is relatively simple. Chlorhexidine and fluoride have been widely used in the prevention and treatment of early dental caries in clinical practice. Both drugs can prevent and treat early dental caries to a certain extent by eliminating cariogenic bacteria or promoting the remineralization of demineralized hard tissues. However, excessive intake of fluoride can cause the emergence of fluoride-resistant strains and induce systemic diseases such as dental fluorosis and skeletal fluorosis. Chlorhexidine is also not suitable for daily use due to its adverse effects such as tooth staining and taste changes. In view of this, we urgently need to develop a safe and comprehensive dental caries prevention and treatment strategy that combines strong antibacterial ability with the promotion of remineralization.
[0003] Antimicrobial photodynamic therapy (aPDT) is an emerging non-invasive antimicrobial therapy that mainly uses various reactive oxygen species (ROS) generated by photosensitizers (PS) under near-infrared light irradiation to destroy bacterial membranes and cell walls. Antimicrobial photodynamic therapy (aPDT) has a strong antibacterial effect and does not produce bacterial resistance, so it has the potential to become an effective strategy for the prevention and treatment of dental caries. However, due to the lack of hydrophilicity of traditional photosensitizers, they are prone to accumulate in the oral saliva microenvironment. Therefore, the application of aPDT in the prevention and treatment of dental caries is still in its infancy. Secondly, the oral microenvironment is complex and dynamically changing, and photosensitizers cannot resist saliva flushing, resulting in their inability to remain on the tooth surface for a long time. Therefore, the key to using aPDT to prevent and treat dental caries lies in the innovative development of an amphiphilic delivery system that can not only significantly improve the water solubility of traditional photosensitizers, but also stably adhere to the tooth surface.
[0004] Dendritic polypeptide nanogels (PDNs) are an emerging biomedical polymer material that combines many unique properties of nanogels and dendritic polymers and can be used as delivery carriers for hydrophilic and hydrophobic drugs. In addition, since PDNs contain a large number of amino functional groups on the periphery, they are easy to be functionalized. The salivary acquired film is a thin film formed by the selective adsorption of salivary proteins and glycoproteins on the tooth surface, which has a high adhesion capacity to the tooth surface. Inspired by this, researchers found that statherin is the main component of the salivary acquired film and exhibits significant adhesion to the tooth surface. In the process of mediating adhesion, the functional region of the N-terminus of statherin plays an important role. In particular, the first six peptide sequences DpSpSEEK (abbreviated as SAP) at the N-terminus of statherin are highly charged and are the key domains for recognizing the tooth surface. It is worth noting that both PDNs and SAP can serve as nucleation templates to promote the remineralization of demineralized tooth hard tissue. PDNs can stabilize phosphate ions in saliva through their abundant terminal amino groups, while the phosphate and carboxyl groups on the side chains of SAP can capture free calcium ions in saliva. They synergistically regulate the orderly growth of hydroxyapatite and promote the in situ remineralization of demineralized tooth hard tissue. Given these properties, PDNs chemically modified with SAP can provide an innovative solution for introducing aPDT into caries prevention. Summary of the invention
[0005] An object of the present invention is to solve at least the above problems and / or disadvantages and to provide at least the advantages which will be described hereinafter.
[0006] In order to achieve these purposes and other advantages according to the present invention, a method for preparing Ce6@PDNs-SAP having wet adhesion, photodynamic antibacterial and in situ remineralization promotion functions is provided, comprising the following steps:
[0007] Step 1, preparing dendritic polypeptide nanogel PDNs rich in lysine;
[0008] Step 2: Preparation of Ce6@PDNs: In a dark environment, Ce6 (dihydrochlorin e6) was dissolved in DMSO, and then added dropwise to the vigorously stirred PDNs aqueous solution to form a micellar suspension. After continued stirring, the suspension was dialyzed with deionized water and freeze-dried to obtain a dark green flocculent product Ce6@PDNs.
[0009] Step 3, preparation of Mal-Ce6@PDNs: 3-maleimidopropionic acid, EDC (1-ethyl-(3-dimethylaminopropyl)carbodiimide) and NHS (N-hydroxysuccinimide) were dissolved in deionized water under nitrogen protection, and the carboxyl groups were activated by reaction at room temperature overnight. The obtained carboxylated maleimide was slowly dripped into the Ce6@PDNs aqueous solution, and the reaction was protected from light, and then lyophilized to obtain the product Mal-Ce6@PDNs;
[0010] Step 4: Preparation of Ce6@PDNs-SAP: Stir the Mal-Ce6@PDNs aqueous solution and the SAP aqueous solution under neutral conditions to obtain the final product Ce6@PDNs-SAP.
[0011] Preferably, in the step 1, the process of preparing the lysine-rich dendritic polypeptide nanogel PDNs is as follows: dissolving G2-Lys in a DMF solvent, slowly dropping a DMF solution of 20 mg DSP (3,3' dithiodipropionic acid di(N-hydroxysuccinimide) ester) into the G2-Lys solution under high-speed stirring, reacting for 24 h, dialyzing in DMF and deionized water in turn, and freeze-drying to obtain a white flocculent product PDNs; the mass volume ratio of the G2-Lys to the DMF solvent is 100 mg: 8-15 mL; the mass volume ratio of the G2-Lys to the DMF solution of DSP is 100 mg: 0.5-1.5 mL; the concentration of the DMF solution of DSP is 15-25 mg / mL; and the molecular weight cutoff of the dialysis bag during dialysis is 1000 Da.
[0012] Preferably, in the step 2, the mass volume ratio of Ce6 to DMSO is 1~3 mg:0.5~2 mL; the mass volume ratio of Ce6 to PDNs aqueous solution is 1~3 mg:8~15 mL; the concentration of the PDNs aqueous solution is 2~5 mg / mL; the continued stirring time is 12~36 hours; and the deionized water dialysis time is 1~3 days.
[0013] Preferably, in the step three, the mass ratio of 3-maleimidopropionic acid to EDC is 1:10~20; the mass ratio of 3-maleimidopropionic acid to NHS is 1:5~15; the mass ratio of 3-maleimidopropionic acid to deionized water is 1:2~5; the mass volume ratio of 3-maleimidopropionic acid to Ce6@PDNs aqueous solution is 1 mg:1.5~3 mL; the concentration of Ce6@PDNs aqueous solution is 3~8 mg / mL; and the light-proof reaction time is 12~36 hours.
[0014] Preferably, in step 4, the concentration of the Mal-Ce6@PDNs aqueous solution is 3~8 mg / mL, and the concentration of the SAP aqueous solution is 0.5~3 mg / mL; the volume ratio of the Mal-Ce6@PDNs aqueous solution to the SAP aqueous solution is 5~15:1; the pH under neutral conditions is 6.5-7.5, and the stirring reaction time is 12~36 hours.
[0015] The present invention also provides an application of Ce6@PDNs-SAP prepared by the preparation method as described above in the preparation of wet adhesive materials.
[0016] The present invention also provides an application of Ce6@PDNs-SAP prepared by the preparation method as described above in the preparation of photodynamic antibacterial materials.
[0017] The present invention also provides an application of Ce6@PDNs-SAP prepared by the preparation method as described above in the preparation of in-situ promoted remineralization materials.
[0018] The present invention also provides an application of Ce6@PDNs-SAP prepared by the preparation method as described above in the preparation of a material having the functions of wet adhesion, photodynamic antibacterial and in-situ promotion of remineralization.
[0019] The present invention also provides an application of Ce6@PDNs-SAP prepared by the preparation method as described above in preparing a dental caries preventing mouthwash.
[0020] The Ce6@PDNs-SAP (abbreviated as CP-SAP) prepared by the present invention has the following characteristics: 1) rapid adhesion and long-term retention on the tooth surface; 2) Ce6-mediated aPDT can effectively eradicate the growth of caries-causing bacteria; 3) SAP and PDNs can both serve as nucleation templates to synergistically promote the in situ remineralization of demineralized tooth hard tissue.
[0021] The present invention includes at least the following beneficial effects: the Ce6@PDNs-SAP prepared by the present invention has the functions of wet adhesion, photodynamic antibacterial and in situ promotion of remineralization, and has been experimentally verified that: (1) Ce6@PDNs-SAP can achieve stable adhesion after acting on hydroxyapatite for 6 minutes; (2) Compared with the PBS control group, the CP-SAP + L group (the process of irradiating with 665 nm near-infrared light for 5 minutes is referred to as "+L") reduced the survival rate of S. m by 4.9 log units, indicating that CP-SAP has a significant antibacterial effect under light; (3) No enamel column structure was observed in the CP-SAP group, and a relatively dense and smooth new regenerated mineral layer was formed on its enamel surface. A continuous and uniform new regenerated mineral layer appeared in its cross section, and no obvious gap was observed between the new layer and the original enamel, indicating that CP-SAP has an excellent ability to promote the remineralization of demineralized enamel in vitro.
[0022] Other advantages, objectives and features of the present invention will be embodied in part through the following description, and in part will be understood by those skilled in the art through study and practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 For G2-Lys and PDNs in D 2 1H NMR spectra in O;
[0024] Figure 2 Figure 2 is the aqueous solution diagram of PDNs and Ce6@PDNs (abbreviated as CP);
[0025] Figure 3 FTIR spectrum of Ce6@PDNs-SAP (abbreviated as CP-SAP);
[0026] Figure 4 Transmission electron microscopy image and particle size distribution of CP-SAP;
[0027] Figure 5 The surface fluorescence images of hydroxyapatite sheets treated with Cy5-labeled CP-SAP for different time periods;
[0028] Figure 6 This is the antibacterial experimental effect diagram of CP-SAP;
[0029] Figure 7 This is the SEM image of the remineralization effect of CP-SAP on tooth enamel. DETAILED DESCRIPTION
[0030] The present invention is further described in detail below in conjunction with the accompanying drawings so that those skilled in the art can implement the invention with reference to the description.
[0031] It should be understood that terms such as “having”, “including” and “comprising” used herein do not specify the existence or addition of one or more other elements or combinations thereof.
[0032] Embodiment 1:
[0033] A method for preparing Ce6@PDNs-SAP having wet adhesion, photodynamic antibacterial and in-situ remineralization promotion functions comprises the following steps:
[0034] Step 1: Preparation of dendritic polypeptide nanogel PDNs rich in lysine: 100 mg of G2-Lys was dissolved in 10 mL of DMF solvent, and 1 mL of DSP DMF solution (20 mg / mL) was slowly added to the G2-Lys solution under high-speed stirring. After reacting for 24 h, the mixture was dialyzed in DMF and deionized water (the molecular weight cutoff of the dialysis bag was 1000 Da), and freeze-dried to obtain a white flocculent product PDNs.
[0035] The preparation method of G2-Lys is as follows: G2-Lys uses polyhedral oligomeric silsesquioxane POSS as the core, and each of the eight Si vertices of the polyhedral structure is connected with a propylamine, which provides a natural branching structure for the synthesis of peptide dendrimers. Then, Boc-protected lysine Boc-Lys(Boc)-OH is activated by a condensing agent, and then reacts with the eight amino groups of POSS respectively to form Boc-protected first-generation lysine dendrimer Boc-G1-Lys, which is then deprotected to form G1-Lys with sixteen amino groups. G2-Lys continues to use G1-Lys as a reaction substrate to form G2-Lys with thirty-two amino groups. The preparation method of G2-Lys is as follows: at room temperature, (3-aminopropyl)triethoxysilane (15 mL, 60 mmol) is dissolved in 350 mL of methanol, the temperature is raised to 50° C. with stirring, and 30 mL of concentrated hydrochloric acid, then heated to 90 ℃, cooled and refluxed, and reacted for 24 h; after the temperature dropped to room temperature, the reaction solution was added to 150 mL of tetrahydrofuran (THF) and stirred at room temperature for 4 h; after centrifugation with THF (3000 rpm, 3 min) and washing three times, the resulting product was placed in a vacuum drying oven to obtain dry white powder POSS; 1 g of POSS (OAS), 2.60 g of Boc-Lys (Boc) -OH (1.1 times the equivalent of amino), 3.36 g of HBTU (1.2 times the equivalent of lysine), and 1.21 g of HOBt (1.2 times the equivalent of lysine) were weighed, dissolved in 50 mL of dimethyl sulfoxide (DMSO) under nitrogen protection, activated in an ice bath for 20 min, and then 5 mL of DIEA was added, and reacted at room temperature for 2 days; 50 mL of the reaction solution was added After mixing with chloroform, wash with saturated brine for 3-5 times to remove DMSO; add anhydrous sodium sulfate to the remaining solution for drying, filter to remove solids; rotary evaporate until the solution becomes viscous, add a small amount of acetonitrile to produce a small amount of precipitation, and then put it in a -20°C refrigerator for recrystallization (about 4 h); after recrystallization, add a large amount of acetonitrile for washing, centrifuge until the supernatant becomes colorless, and vacuum dry to obtain solid Boc-G1-Lys; the dried solid is dissolved in chloroform, add ten times the equivalent of trifluoroacetic acid (TFA) and stir overnight, then rotary evaporate until the solution becomes viscous; drop the viscous liquid into ether, precipitate while stirring, continue stirring (the time is not fixed, mainly to make the precipitate evenly dispersed, a few hours is enough, or overnight), centrifuge, wash with ether, centrifuge 3-5 times, and vacuum dry to obtain G1-Lys white powder; the synthesis method of G2-Lys is the same as that of G1-Lys, that is, weigh 1 g of G1-Lys, Boc-Lys(Boc)-OH 1.79 g (1.92 g) (1.2 times the equivalent of amino group), HBTU 2.35 g (2.1 g) (1.2 times the equivalent of lysine), HOBt 0.87 g (0.75g) (1.2 times the equivalent of lysine), dissolved in 50 mL of dimethyl sulfoxide under nitrogen protection, activated in an ice bath for 20 min, then added with 3.4 mL (4 times the equivalent of amino group) of DIEA, and reacted at room temperature for 2 days. Add 50 mL of chloroform to the reaction solution and mix well, then wash with saturated brine for 3-5 times to remove DMSO; add anhydrous sodium sulfate to the remaining solution to dry, filter and remove solids; evaporate until the solution becomes viscous, add a small amount of acetonitrile to produce a small amount of precipitation, and then place in a -20℃ refrigerator for recrystallization (about 4 h); after recrystallization, add a large amount of acetonitrile to wash, centrifuge until the supernatant becomes colorless, and vacuum dry to obtain solid Boc-Lys-G2; dissolve the dried solid in chloroform, add ten times the equivalent of trifluoroacetic acid (TFA) and stir overnight, then evaporate until the solution becomes viscous; drop the viscous solution into ether, precipitate while stirring, continue stirring (the time is not fixed, mainly to make the precipitate evenly dispersed, a few hours is enough, or overnight), centrifuge, wash with ether, centrifuge 3-5 times, and vacuum dry to obtain G2-Lys white powder;.
[0036] Step 2: Preparation of Ce6@PDNs: In a dark environment, 2 mg of Ce6 was dissolved in 1 mL of DMSO, and then added dropwise to a vigorously stirred 10 mL of PDNs aqueous solution (3 mg / mL). After stirring for 24 h, the mixture was dialyzed with deionized water for 2 d and freeze-dried to obtain a dark green flocculent product, Ce6@PDNs.
[0037] Step 3: Dissolve 5 mg 3-maleimidopropionic acid, 80 mg EDC and 50 mg NHS in 15 mL deionized water under nitrogen protection, react overnight at room temperature to activate the carboxyl group, slowly drop the obtained carboxylated maleimide into 10 mL Ce6@PDNs (5 mg / mL) aqueous solution, react in the dark for 24 h, and then freeze-dry to obtain the product Mal-Ce6@PDNs;
[0038] Step 4. Preparation of Ce6@PDNs-SAP: 10 mL of Mal-Ce6@PDNs aqueous solution (4 mg / mL) and 1 mL of SAP aqueous solution (1 mg / mL) were stirred under neutral conditions (pH = 6.5-7.5) for 24 h to obtain the final product Ce6@PDNs-SAP.
[0039] The materials prepared by the present invention are characterized:
[0040] Figure 1 For G2-Lys and PDNs in D 21H NMR spectrum in O; the results showed that a new chemical shift attributed to the methylene group of DSP cross-linker appeared at 2.51-2.71 ppm in 1H NMR, proving the successful synthesis of PDNs;
[0041] Figure 2 The aqueous solution of PDNs and Ce6@PDNs (CP for short) is shown in Figure 2. The results show that after loading Ce6, the color of the solution changes from colorless to dark green, proving that the drug loading is successful.
[0042] Figure 3 FTIR spectrum of Ce6@PDNs-SAP (CP-SAP for short). The results show that the SAP spectrum is at 1730 cm -1 There is a small peak at 1088 cm, which corresponds to the thiol group of cysteine in SAP. In the spectrum of Ce6@PDNs-SAP (abbreviated as CP-SAP), the thiol band disappears and the peak at 1088 cm -1 and 664 cm -1 Two new peaks were generated at , and these new extensions appeared during the production of thioether groups attached to the conjugation between SAP and Mal-Ce6@PDNs, demonstrating a successful connection and the successful synthesis of Ce6@PDNs-SAP.
[0043] Figure 4 Transmission electron microscope image and particle size distribution of CP-SAP; the results show that the particle size of CP-SAP is 246±12 nm, which is consistent with the results shown by SEM.
[0044] Application Example 1:
[0045] An application of Ce6@PDNs-SAP prepared by the preparation method described in Example 1 in the preparation of a wet adhesive material;
[0046] Adhesion performance evaluation:
[0047] CP and CP-SAP were labeled with Cy5, a fluorescent dye marker, and adhesion-related fluorescence microscopy studies were subsequently performed. First, 2 mL of CP and CP-SAP aqueous solutions (at a concentration of 500 μg / mL) were mixed with 50 μL of Cy5-NHS ester (at a concentration of 500 μg / mL) in dimethyl sulfoxide (DMSO) and the mixture was stirred at room temperature for 4 h. Afterwards, the mixture was dialyzed thoroughly with deionized water, and the product was collected after lyophilization. Then, hydroxyapatite sheets (HAP) with a size of 5 × 5 × 2 mm were placed in 1 mL of Cy5-labeled CP and CP-SAP aqueous solutions at a concentration of 200 μg / mL for 2, 4, 6, and 8 min, respectively. Subsequently, the HAP sheets were removed and washed with deionized water to remove any material that was not completely adhered to the surface. After drying the samples, the wet adhesion of CP-SAP was observed by observing the fluorescence intensity on the HAP sheets after treatment for different times using an upright fluorescence microscope;
[0048] Results: The results showed that CP-SAP could achieve stable adhesion on hydroxyapatite after 6 minutes.
[0049] Application Example 2:
[0050] An application of Ce6@PDNs-SAP prepared by the preparation method described in Example 1 in the preparation of photodynamic antibacterial materials;
[0051] Antimicrobial performance evaluation:
[0052] Procedure: Initially, 950 μL of Streptococcus mutans (S. 9 CFU / mL) suspension was mixed with 50 μL of CP-SAP (4 mg / mL) and other different treatment groups; the resulting mixture was then placed in an EP tube and irradiated with a laser with a wavelength of 665 nm and a laser power density of 214 mW / cm 2 After laser irradiation, the mixture was further incubated for 30 minutes; then, the mixture was collected and graded diluted to obtain concentrations ranging from 10 6 to 10 2 CFU / mL of five mixed solutions; then, 5 μL of solution from each group was dropped on a BHI agar plate and incubated overnight at 37°C and 5% carbon dioxide; finally, the number of colonies formed on the plate was counted and the survival rate of the bacteria was calculated.
[0053] Results: Compared with the PBS control group, the CP-SAP + L group reduced the survival rate of S. m by 4.9 log units, indicating that CP-SAP has a significant antibacterial effect under light irradiation. (The process of irradiating with 665 nm near-infrared light for 5 min is referred to as "+L")
[0054] Application Example 3:
[0055] An application of Ce6@PDNs-SAP prepared by the preparation method described in Example 1 in the preparation of an in-situ promoted remineralization material;
[0056] Evaluation of remineralization performance:
[0057] Procedure: Prepare bovine enamel slices, leave a 1×1 cm area in the center, seal the surrounding area with nail polish, etch with 35% phosphoric acid for 5 min, polish, and then wash with deionized water for 1 min. Then soak the bovine enamel slices in CP-SAP solution for 5 min. After soaking, rinse the sample with sterile PBS to ensure that unattached materials are removed. Place the treated bovine enamel slices in 1 mL of artificial saliva and shake them in an artificial shaker (37°C, 100 rpm). Repeat the above administration process every 12 h. Take them out after 5 days, dry them, spray gold, and sputter them, and use a scanning electron microscope to observe the changes in the enamel surface structure and morphology.
[0058] Results: The enamel surface after acid etching and demineralization showed a "fish scale" shape under SEM, showing a distinct enamel prism structure. In artificial saliva, the blank control group still showed an irregular pore-like structure after 5 days of natural remineralization, and no new layer was observed in the cross section. The enamel prism structure of the demineralized enamel surface treated with SAP faded, but it showed a rough surface with many cracks, and a relatively sparse crystalline remineralization layer appeared in the cross section, suggesting the formation of a thin new regenerated mineralization layer. The microscopic results of CP-SAP and SAP were similar, showing a limited remineralization effect to a certain extent, which is because it cannot remain on the enamel surface for a long time and continue to play a role. However, no enamel prism structure was observed in the CP-SAP group, and a relatively dense and smooth new regenerated mineral layer was formed on its enamel surface. A continuous and uniform new regenerated mineralization layer appeared in its cross section, and no obvious gaps were observed between the new layer and the original enamel, indicating that CP-SAP has excellent ability to promote the remineralization of demineralized enamel in vitro.
[0059] Application example 4:
[0060] An application of Ce6@PDNs-SAP prepared by the preparation method described in Example 1 in the preparation of functional materials with wet adhesion, photodynamic antibacterial and in situ promotion of remineralization.
[0061] Application Example 5:
[0062] A use of Ce6@PDNs-SAP prepared by the preparation method described in Example 1 in the preparation of a dental caries preventing mouthwash.
[0063] Although the embodiments of the present invention have been disclosed as above, they are not limited to the applications listed in the specification and the implementation modes, and they can be fully applied to various fields suitable for the present invention. For those familiar with the art, additional modifications can be easily implemented. Therefore, without departing from the general concept defined by the claims and the scope of equivalents, the present invention is not limited to the specific details and the illustrations shown and described herein.
Claims
1. A method for preparing Ce6@PDNs-SAP with wet adhesion, photodynamic antibacterial and in-situ remineralization promotion functions, characterized in that: The following steps are involved: Step 1, preparing dendritic polypeptide nanogel PDNs rich in lysine; Step 2: Preparation of Ce6@PDNs: In a dark environment, Ce6 was dissolved in DMSO, and then added dropwise to a vigorously stirred aqueous solution of PDNs to form a micellar suspension. After continued stirring, the suspension was dialyzed with deionized water and freeze-dried to obtain a dark green flocculent product Ce6@PDNs. Step 3, preparation of Mal-Ce6@PDNs: 3-maleimidopropionic acid, EDC and NHS were dissolved in deionized water under nitrogen protection, and the carboxyl groups were activated by reaction at room temperature overnight. The obtained carboxylated maleimide was slowly dripped into the Ce6@PDNs aqueous solution, and after the reaction in the dark, the product Mal-Ce6@PDNs was obtained by freeze-drying; Step 4: Preparation of Ce6@PDNs-SAP: Stir the Mal-Ce6@PDNs aqueous solution and the SAP aqueous solution under neutral conditions to obtain the final product Ce6@PDNs-SAP.
2. The method for preparing Ce6@PDNs-SAP having the functions of wet adhesion, photodynamic antibacterial and in-situ promotion of remineralization as claimed in claim 1, characterized in that: In the step 1, the process of preparing the dendritic polypeptide nanogel PDNs rich in lysine is as follows: dissolving G2-Lys in DMF solvent, slowly dropping 20 mg of DSP in DMF solution into the G2-Lys solution under high-speed stirring, reacting for 24 hours, dialyzing in DMF and deionized water in turn, and freeze-drying to obtain a white flocculent product PDNs; the mass volume ratio of the G2-Lys to the DMF solvent is 100 mg: 8-15 mL; the mass volume ratio of the G2-Lys to the DMF solution of DSP is 100 mg: 0.5-1.5 mL; the concentration of the DMF solution of DSP is 15-25 mg / mL; and the molecular weight cutoff of the dialysis bag during dialysis is 1000 Da.
3. The method for preparing Ce6@PDNs-SAP having the functions of wet adhesion, photodynamic antibacterial and in-situ promotion of remineralization as claimed in claim 1, characterized in that: In the step 2, the mass volume ratio of Ce6 to DMSO is 1~3mg:0.5~2mL; the mass volume ratio of Ce6 to PDNs aqueous solution is 1~3mg:8~15mL; the concentration of the PDNs aqueous solution is 2~5mg / mL; the stirring time is continued for 12~36 hours; and the deionized water dialysis time is 1~3d.
4. The method for preparing Ce6@PDNs-SAP having wet adhesion, photodynamic antibacterial and in-situ remineralization promotion functions as claimed in claim 1, characterized in that: In the step three, the mass ratio of 3-maleimidopropionic acid to EDC is 1:10~20; the mass ratio of 3-maleimidopropionic acid to NHS is 1:5~15; the mass ratio of 3-maleimidopropionic acid to deionized water is 1:2~5; the mass volume ratio of 3-maleimidopropionic acid to Ce6@PDNs aqueous solution is 1 mg:1.5~3 mL; the concentration of Ce6@PDNs aqueous solution is 3~8 mg / mL; the light-proof reaction time is 12~36 hours.
5. The method for preparing Ce6@PDNs-SAP having the functions of wet adhesion, photodynamic antibacterial and in-situ promotion of remineralization as claimed in claim 1, characterized in that: In the step 4, the concentration of the Mal-Ce6@PDNs aqueous solution is 3-8 mg / mL, and the concentration of the SAP aqueous solution is 0.5-3 mg / mL; the volume ratio of the Mal-Ce6@PDNs aqueous solution to the SAP aqueous solution is 5-15:1; the pH under neutral conditions is 6.5-7.5, and the stirring reaction time is 12-36 hours.
6. Use of Ce6@PDNs-SAP prepared by the preparation method according to any one of claims 1 to 5 in the preparation of wet adhesive materials.
7. Use of Ce6@PDNs-SAP prepared by the preparation method according to any one of claims 1 to 5 in the preparation of photodynamic antibacterial materials.
8. Use of Ce6@PDNs-SAP prepared by the preparation method according to any one of claims 1 to 5 in the preparation of in-situ promoted remineralization materials.
9. Use of Ce6@PDNs-SAP prepared by the preparation method according to any one of claims 1 to 5 in the preparation of functional materials with wet adhesion, photodynamic antibacterial and in-situ promotion of remineralization.
10. Use of Ce6@PDNs-SAP prepared by the preparation method according to any one of claims 1 to 5 in preparing a dental caries preventing mouthwash.
